Corbus Pharmaceuticals Holdings (CRBP) Cash & Current Investments (2013 - 2025)

Corbus Pharmaceuticals Holdings' Cash & Current Investments history runs 13 years deep, the most recent figure standing at $27.8 million for Q4 2025.

• In Q4 2025, Cash & Current Investments fell 80.69% year-over-year to $27.8 million; the TTM figure through Dec 2025 stood at $27.8 million (down 80.69% YoY), while the FY2025 annual figure was $27.8 million, down 80.69% from the prior year.
• Cash & Current Investments was $27.8 million for Q4 2025 at Corbus Pharmaceuticals Holdings, up from $25.8 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $144.0 million in Q4 2024 to a low of $3.7 million in Q1 2021.
• Historically, Cash & Current Investments has averaged $49.7 million across 5 years, with a median of $31.3 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Cash & Current Investments tumbled 95.6% in 2022, then surged 1356.61% in 2024.
• A 5-year view of Cash & Current Investments shows it stood at $90.9 million in 2021, then sank by 95.6% to $4.0 million in 2022, then surged by 147.32% to $9.9 million in 2023, then soared by 1356.61% to $144.0 million in 2024, then tumbled by 80.69% to $27.8 million in 2025.
• The last three Cash & Current Investments figures came in at $27.8 million (Q4 2025), $25.8 million (Q3 2025), and $114.3 million (Q2 2025), per Business Quant data.